Is the FDA contributing to the homelessness crisis?
The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...
The American Journal of Managed Care1d
FDA Approves Gene Therapy to Treat AADC Deficiency
The approval marks the first time gene therapy will be available to treat patients with aromatic I-amino acid decarboxylase ...
PTC Therapeutics, Inc.: PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
First-ever FDA approval for gene therapy directly administered to the brain - - Priority review voucher granted - - Broad label including children and adults - - ...
pulmonologyadvisor2d
Air Pollution Exposure May Up Risk for Parkinson Disease and Dyskinesia
Air pollution exposure is associated with an increased risk of developing Parkinson disease (PD) and dyskinesia, according to study results published in JAMA Network Open.
Stockhouse2d
PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
Patients should be monitored for procedure related adverse events with KEBILIDI administration. Dyskinesia: Dyskinesia was reported after administration of KEBILIDI. All events were reported within 3 ...
Supernus Pharmaceuticals: Recently Launched Qelbree Is Powering Growth
Supernus Pharmaceuticals is reaping the benefits of its ADHD drug Qelbree, with strong Q3 results and upwardly revised ...